SGLT2 inhibitors: a therapy for everybody but not for anything?

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of preventive cardiology 2024-05, Vol.31 (7), p.768-769
Hauptverfasser:	Villaschi, Alessandro, Cesani, Nicola, Chiarito, Mauro
Format:	Artikel
Sprache:	eng
Schlagworte:	Blood Glucose - drug effects Blood Glucose - metabolism Cardiovascular Diseases - drug therapy Diabetes Mellitus, Type 2 - drug therapy Humans Hypoglycemic Agents - therapeutic use Sodium-Glucose Transporter 2 Inhibitors - adverse effects Sodium-Glucose Transporter 2 Inhibitors - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	769
container_issue	7
container_start_page	768
container_title	European journal of preventive cardiology
container_volume	31
creator	Villaschi, Alessandro Cesani, Nicola Chiarito, Mauro
description
doi_str_mv	10.1093/eurjpc/zwad372
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2899374257</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2899374257</sourcerecordid><originalsourceid>FETCH-LOGICAL-c290t-dabacbca213e7038db6c26a5ceb28763f901172a6767942a2d9d1e1bb6e77b6c3</originalsourceid><addsrcrecordid>eNo9kD1PwzAQhi0EolXpyog8sqT1RxLbLBWqoCBVYqDMkT8uNFWbBDsBhV9PoKG33OnVc-_wIHRNyYwSxefQ-l1t599f2nHBztCYkVhEsZT0_HQLPkLTEHakn5QwJuUlGnFJEkGTeIwWr6v1huGi3BamaCof7rDGzRa8rjucVx7DJ_jOVK7Dpm1wWTV_qS67ZluU74srdJHrfYDpsCfo7fFhs3yK1i-r5-X9OrJMkSZy2mhrrGaUgyBcOpNalurEgmFSpDxXhFLBdCpSoWKmmVOOAjUmBSF6lk_Q7bG39tVHC6HJDkWwsN_rEqo2ZEwqxUXMEtGjsyNqfRWChzyrfXHQvssoyX69ZUdv2eCtf7gZultzAHfC_y3xH1g7atw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2899374257</pqid></control><display><type>article</type><title>SGLT2 inhibitors: a therapy for everybody but not for anything?</title><source>MEDLINE</source><source>Oxford Journals Online</source><creator>Villaschi, Alessandro ; Cesani, Nicola ; Chiarito, Mauro</creator><creatorcontrib>Villaschi, Alessandro ; Cesani, Nicola ; Chiarito, Mauro</creatorcontrib><identifier>ISSN: 2047-4873</identifier><identifier>ISSN: 2047-4881</identifier><identifier>EISSN: 2047-4881</identifier><identifier>DOI: 10.1093/eurjpc/zwad372</identifier><identifier>PMID: 38057154</identifier><language>eng</language><publisher>England</publisher><subject>Blood Glucose - drug effects ; Blood Glucose - metabolism ; Cardiovascular Diseases - drug therapy ; Diabetes Mellitus, Type 2 - drug therapy ; Humans ; Hypoglycemic Agents - therapeutic use ; Sodium-Glucose Transporter 2 Inhibitors - adverse effects ; Sodium-Glucose Transporter 2 Inhibitors - therapeutic use ; Treatment Outcome</subject><ispartof>European journal of preventive cardiology, 2024-05, Vol.31 (7), p.768-769</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c290t-dabacbca213e7038db6c26a5ceb28763f901172a6767942a2d9d1e1bb6e77b6c3</cites><orcidid>0000-0002-9333-2658 ; 0000-0002-7981-7894</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38057154$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Villaschi, Alessandro</creatorcontrib><creatorcontrib>Cesani, Nicola</creatorcontrib><creatorcontrib>Chiarito, Mauro</creatorcontrib><title>SGLT2 inhibitors: a therapy for everybody but not for anything?</title><title>European journal of preventive cardiology</title><addtitle>Eur J Prev Cardiol</addtitle><subject>Blood Glucose - drug effects</subject><subject>Blood Glucose - metabolism</subject><subject>Cardiovascular Diseases - drug therapy</subject><subject>Diabetes Mellitus, Type 2 - drug therapy</subject><subject>Humans</subject><subject>Hypoglycemic Agents - therapeutic use</subject><subject>Sodium-Glucose Transporter 2 Inhibitors - adverse effects</subject><subject>Sodium-Glucose Transporter 2 Inhibitors - therapeutic use</subject><subject>Treatment Outcome</subject><issn>2047-4873</issn><issn>2047-4881</issn><issn>2047-4881</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kD1PwzAQhi0EolXpyog8sqT1RxLbLBWqoCBVYqDMkT8uNFWbBDsBhV9PoKG33OnVc-_wIHRNyYwSxefQ-l1t599f2nHBztCYkVhEsZT0_HQLPkLTEHakn5QwJuUlGnFJEkGTeIwWr6v1huGi3BamaCof7rDGzRa8rjucVx7DJ_jOVK7Dpm1wWTV_qS67ZluU74srdJHrfYDpsCfo7fFhs3yK1i-r5-X9OrJMkSZy2mhrrGaUgyBcOpNalurEgmFSpDxXhFLBdCpSoWKmmVOOAjUmBSF6lk_Q7bG39tVHC6HJDkWwsN_rEqo2ZEwqxUXMEtGjsyNqfRWChzyrfXHQvssoyX69ZUdv2eCtf7gZultzAHfC_y3xH1g7atw</recordid><startdate>20240511</startdate><enddate>20240511</enddate><creator>Villaschi, Alessandro</creator><creator>Cesani, Nicola</creator><creator>Chiarito, Mauro</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9333-2658</orcidid><orcidid>https://orcid.org/0000-0002-7981-7894</orcidid></search><sort><creationdate>20240511</creationdate><title>SGLT2 inhibitors: a therapy for everybody but not for anything?</title><author>Villaschi, Alessandro ; Cesani, Nicola ; Chiarito, Mauro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c290t-dabacbca213e7038db6c26a5ceb28763f901172a6767942a2d9d1e1bb6e77b6c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Blood Glucose - drug effects</topic><topic>Blood Glucose - metabolism</topic><topic>Cardiovascular Diseases - drug therapy</topic><topic>Diabetes Mellitus, Type 2 - drug therapy</topic><topic>Humans</topic><topic>Hypoglycemic Agents - therapeutic use</topic><topic>Sodium-Glucose Transporter 2 Inhibitors - adverse effects</topic><topic>Sodium-Glucose Transporter 2 Inhibitors - therapeutic use</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Villaschi, Alessandro</creatorcontrib><creatorcontrib>Cesani, Nicola</creatorcontrib><creatorcontrib>Chiarito, Mauro</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of preventive cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Villaschi, Alessandro</au><au>Cesani, Nicola</au><au>Chiarito, Mauro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>SGLT2 inhibitors: a therapy for everybody but not for anything?</atitle><jtitle>European journal of preventive cardiology</jtitle><addtitle>Eur J Prev Cardiol</addtitle><date>2024-05-11</date><risdate>2024</risdate><volume>31</volume><issue>7</issue><spage>768</spage><epage>769</epage><pages>768-769</pages><issn>2047-4873</issn><issn>2047-4881</issn><eissn>2047-4881</eissn><cop>England</cop><pmid>38057154</pmid><doi>10.1093/eurjpc/zwad372</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-9333-2658</orcidid><orcidid>https://orcid.org/0000-0002-7981-7894</orcidid><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 2047-4873
ispartof	European journal of preventive cardiology, 2024-05, Vol.31 (7), p.768-769
issn	2047-4873 2047-4881 2047-4881
language	eng
recordid	cdi_proquest_miscellaneous_2899374257
source	MEDLINE; Oxford Journals Online
subjects	Blood Glucose - drug effects Blood Glucose - metabolism Cardiovascular Diseases - drug therapy Diabetes Mellitus, Type 2 - drug therapy Humans Hypoglycemic Agents - therapeutic use Sodium-Glucose Transporter 2 Inhibitors - adverse effects Sodium-Glucose Transporter 2 Inhibitors - therapeutic use Treatment Outcome
title	SGLT2 inhibitors: a therapy for everybody but not for anything?
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T19%3A37%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=SGLT2%20inhibitors:%20a%20therapy%20for%20everybody%20but%20not%20for%20anything?&rft.jtitle=European%20journal%20of%20preventive%20cardiology&rft.au=Villaschi,%20Alessandro&rft.date=2024-05-11&rft.volume=31&rft.issue=7&rft.spage=768&rft.epage=769&rft.pages=768-769&rft.issn=2047-4873&rft.eissn=2047-4881&rft_id=info:doi/10.1093/eurjpc/zwad372&rft_dat=%3Cproquest_cross%3E2899374257%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2899374257&rft_id=info:pmid/38057154&rfr_iscdi=true